Mirvie

A personalized window into pregnancy health

Mirvie was founded in 2018, is headquartered in San Francisco Bay Area, United States, lists 11–50 employees, and has $118.3M in recorded funding across 4 rounds.

Employees
11–50
Founded
2018
Website
mirvie.com
Total Funding
$118.3M
Last Round
$23.7M Venture RoundAug 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 9 investors for this company. The full record is or through the API.

About

Mirvie is a women's health company that has developed a proprietary RNA platform to predict pregnancy complications months before symptoms appear using a simple blood draw. The platform analyzes tens of thousands of RNA messages from the baby, placenta, and mother, combining them with machine learning to identify risk for conditions like preeclampsia and preterm birth. Its Encompass test for preeclampsia received clinical validation in studies published in Nature and other peer-reviewed journals.

Summary

Mirvie is a Life Sciences company based in San Francisco Bay Area, United States, founded in 2018. It lists 11–50 employees. It has raised $118.3M in total across 4 rounds, most recently a $23.7M Venture Round in Aug 2025. Investors include BlackRock, Decheng Capital and Foresite Capital.

Tech & App Stack

11 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundAug 2025
$23.7M

Sign up to see all 4 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mirvie on Indexed.vc
<a href="https://indexed.vc/companies/mirvie"><img src="https://indexed.vc/api/badge/company/mirvie" alt="Mirvie on Indexed.vc" width="260" height="76" /></a>